Page 2
We encourage you to attentively read these discussions, pay attention to the professional journals and exhaustively seek lectures on glaucoma. As always, we are grateful to Bausch + Lomb Pharmaceuticals for their unwavering support of this optometric educational product through the years, and to the editorial team at Review of Optometry for helping shape this supplement into a highly readable work. We hope and pray that each of you and your loved ones endure this viral assault, and come out of this disaster stronger and more resolute than ever before. With our best wishes, Drs. Melton, Thomas and Vollmer Disclosure: Drs. Melton and Thomas are consultants to, but have no financial interests in, the following companies: Bausch + Lomb and Icare. Dr. Vollmer has no financial interests in any company. Note: The authors present unapproved and “off-label” uses of specific drugs in this publication. A PEER-REVIEWED SUPPLEMENT Ron Melton, OD, FAAO Patrick M. Vollmer, OD, FAAO Randall K. Thomas, OD, MPH, FAAO FROM THE AUTHORS Section I: Strategies for Success Page 3 Section II: Anterior Segment Care Page 18 Section III: Posterior Segment Care Page 34 Supported by an unrestricted grant from Bausch + Lomb ON PATIENT CARE CLINICAL PERSPECTIVES See the practice of optometry through the eyes of three experts. Ron Melton, OD Randall Thomas, OD, MPH Patrick Vollmer, OD Supported by an unrestricted grant from Bausch + Lomb A Supplement to REVIEW OF OPTOMETRY JUNE 15, 2020 3 Warning: Major Changes Coming to Optometry SECTION I: STRATEGIES FOR SUCCESS STRATEGIES FOR SUCCESS Aquick look at the professional literature clearly shows major sea changes in how eye care is being delivered. Online refractions, eyeglasses and contact lenses are already available in many places of the world, and are now available in the United States.